GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO) » Definitions » Asset Turnover

X Bioscience PCL (BKK:XBIO) Asset Turnover : 0.09 (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is X Bioscience PCL Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. X Bioscience PCL's Revenue for the three months ended in Dec. 2024 was ฿98.8 Mil. X Bioscience PCL's Total Assets for the quarter that ended in Dec. 2024 was ฿1,111.2 Mil. Therefore, X Bioscience PCL's Asset Turnover for the quarter that ended in Dec. 2024 was 0.09.

Asset Turnover is linked to ROE % through Du Pont Formula. X Bioscience PCL's annualized ROE % for the quarter that ended in Dec. 2024 was -138.71%. It is also linked to ROA % through Du Pont Formula. X Bioscience PCL's annualized ROA % for the quarter that ended in Dec. 2024 was -48.53%.


X Bioscience PCL Asset Turnover Historical Data

The historical data trend for X Bioscience PCL's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X Bioscience PCL Asset Turnover Chart

X Bioscience PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.20 0.34 0.43 0.30

X Bioscience PCL Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.10 0.09 0.09 0.09

Competitive Comparison of X Bioscience PCL's Asset Turnover

For the Food Distribution subindustry, X Bioscience PCL's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


X Bioscience PCL's Asset Turnover Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, X Bioscience PCL's Asset Turnover distribution charts can be found below:

* The bar in red indicates where X Bioscience PCL's Asset Turnover falls into.


;
;

X Bioscience PCL Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

X Bioscience PCL's Asset Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=319.244/( (739.389+1414.355)/ 2 )
=319.244/1076.872
=0.30

X Bioscience PCL's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=98.847/( (808.023+1414.355)/ 2 )
=98.847/1111.189
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


X Bioscience PCL  (BKK:XBIO) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

X Bioscience PCL's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-539.28/388.77
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-539.28 / 395.388)*(395.388 / 1111.189)*(1111.189/ 388.77)
=Net Margin %*Asset Turnover*Equity Multiplier
=-136.39 %*0.3558*2.8582
=ROA %*Equity Multiplier
=-48.53 %*2.8582
=-138.71 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

X Bioscience PCL's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=-539.28/1111.189
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-539.28 / 395.388)*(395.388 / 1111.189)
=Net Margin %*Asset Turnover
=-136.39 %*0.3558
=-48.53 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


X Bioscience PCL Asset Turnover Related Terms

Thank you for viewing the detailed overview of X Bioscience PCL's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


X Bioscience PCL Business Description

Traded in Other Exchanges
Address
Phahon Yothin Road, No.304, Room No.1803-1806, 18th Floor, Vanit Place Aree Tower (Tower A, Sam Sen Nai, Bangkok, THA, 10400
X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.